GLP-1 Drugs Need Continued Use for Long-Term Success

University of Oxford found stopping GLP-1 injections leads to rapid weight regain within two years.
GLP-1 agonists mimic gut hormones to reduce appetite and weight.
Meta-analysis of 37 trials with 9341 participants showed 8.3kg weight loss on average.
NHS limits semaglutide to two years due to cost and access issues.
Two million British adults used GLP-1 injections last year.
Experts suggest these treatments may need lifelong use.
Long-term strategies with behavioral support are essential.

Health | Medicine | Weight Loss

United Kingdom

Jebb | Garron Dodd | Dr. Adam Collins

1 week ago